Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

XORTX acquired the Vectus Biosystems program
24 October 2025

XORTX acquired the Vectus Biosystems program

Image Credit: Xortx Announcement  XORTX Therapeutics Inc., a leading late-stage clinical pharmaceutical company, aims to establish creative therapies for the treatment of progressive kidney disease and gout conditions, has signed a binding term sheet for the acquisition of Vectus Biosystems...

Corvus’s new presentation at the ESMO congress 2025
24 October 2025

Corvus’s new presentation at the ESMO congress 2025

Image Credit: The Manila Times Announcement  Corvus Pharmaceuticals Inc., a leading clinical-level biopharmaceutical company, will be showcasing the interim data from the comprehensive phase 1b/2 clinical trial of ciforadenant for metastatic renal cell cancer (RCC) patients today in the ora...

Novo Nordisk’s oral semaglutide confirmed for CV risk reduction
24 October 2025

Novo Nordisk’s oral semaglutide confirmed for CV risk reduction

Image Credit: ChemXplore Announcement  Novo Nordisk received approval from the US Food and Drug Administration (FDA) for Rybelsus. The Rybelsus® is the first ever GLP-1 medication for alleviating the risk of crucial adverse cardiovascular events (MACE) like heart attack, stroke or cardi...

AB Science’s initial phase one data (update) on the AB8939 program in AML disclosed
22 October 2025

AB Science’s initial phase one data (update) on the AB8939 program in AML disclosed

Image Credit: americanbuilt. app Announcement  AB Science, a leading French pharmaceutical company, aims to establish novel drugs to offer unmet medical needs for conditions like neurology, inflammation, and oncology has delivered initial phase 1 data for the merger of AB8939 with relapsed ...

Genentech’s first-ever DTP program in support of trumps goals and major advancement in the flu season
22 October 2025

Genentech’s first-ever DTP program in support of trumps goals and major advancement in the flu season

Image Credit: Pharmafile Announcement  Genentech, a valuable member of the Roche Group, launched the company’s first-ever direct-to-patient (DTP) program. The program strongly contributes to President Trump’s goal to deliver affordable medicines to American patients, specificall...

Ansell’s new tech solution with aerofit ™ technology
22 October 2025

Ansell’s new tech solution with aerofit ™ technology

Image Credit: Ansell Announcement  Ansell Limited, a known expert in protection solutions, introduced the hyflex™ precision comfort series with the AEROFIT™ technology. It’s a new addition of industrial gloves engineered to elevate productivity and precision of workers by ...

Sanofi in millions of deal with EVOQ
22 October 2025

Sanofi in millions of deal with EVOQ

Image Credit: Business Standard Announcement  Sanofi is making headlines with another autoimmune pact by joining Chicago’s EVOQ Therapeutics for its exclusive technology that focuses on restoring the natural immune tolerance in the body. The partners are yet to reveal their primary in...

Arima Genomics’ new study shows multipurpose advantage
20 October 2025

Arima Genomics’ new study shows multipurpose advantage

Image Credit: Yahoo Finance Announcement  The Arima Genomics, Inc., a leading structure information and whole-genome sequence-focused company serving robust cancer therapy selection insights, has declared its new study led by an investigator group at Johns Hopkins University, highlighting t...

Bio-Techne and Saguaro enter a distribution agreement
20 October 2025

Bio-Techne and Saguaro enter a distribution agreement

Image Credit: Stock Titan Announcement  The Saguaro Biosciences, a leader in non-toxic live cell reagents for improved drug insights, has entered a distributive partnership agreement with Bio-Techne Corporation, a leading provider of science tools, diagnostic and reagents products. The coll...

PharmaTher's new AI platform to fuel extensive growth of ketamine portfolio
20 October 2025

PharmaTher's new AI platform to fuel extensive growth of ketamine portfolio

Image Credit: Newsfile Corp Announcement The Pharmather Holdings Ltd, a leading speciality life sciences company targeting the discovery of the pharmaceutical capability of ketamine, has introduced a new ketAlmine™. It’s a patented ketamine exploratory and redefined platform engineer...